Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry
This study offers valuable insights into the clinical characteristics, management, and outcomes of HCC patients in Spain in a real-world setting. Our results suggest potential benefits of immunotherapy-based combinations over other available alternatives, supporting findings from interventional and real-world studies.
Authors
- Ana Fernández Montés (ORCID: https://orcid.org/0000-0003-4630-5830)
- Eva Martínez de Castro (ORCID: https://orcid.org/0000-0002-5772-0741)
- Miriam Lobo (ORCID: https://orcid.org/0000-0002-8249-7721)
- Roberto Pazo-Cid (ORCID: https://orcid.org/0000-0002-8026-7391)
- Mercedes Rodríguez Garrote (ORCID: https://orcid.org/0000-0003-0486-6760)
- Javier Gállego (ORCID: https://orcid.org/0000-0002-0584-1242)
- Beatriz García-Paredes (ORCID: https://orcid.org/0000-0003-3562-1600)
- Adelaida La Casta (ORCID: https://orcid.org/0000-0002-7235-6378)
- Ana Ruiz‐Casado (ORCID: https://orcid.org/0000-0002-7672-2638)
- E. Jiménez Orozco (ORCID: https://orcid.org/0000-0002-3392-9321)
- Juana María Cano (ORCID: https://orcid.org/0000-0002-2493-0988)
- Jorge Adeva (ORCID: https://orcid.org/0000-0002-3959-4120)
- R. Vidal Tocino (ORCID: https://orcid.org/0000-0002-0588-2001)
- Teresa García (ORCID: https://orcid.org/0000-0003-0110-8016)
- Javier Sastre (ORCID: https://orcid.org/0000-0001-6538-0065)
- Sandra López Peraita (ORCID: https://orcid.org/0000-0002-7426-109X)
- Ruth Vera (ORCID: https://orcid.org/0000-0003-1524-3147)
- Mariona Calvo (ORCID: https://orcid.org/0000-0001-6242-0500)
- Paula Cerdá (ORCID: https://orcid.org/0000-0003-0101-188X)
Institutions
- Instituto Cajal (ES)
- Hospital de Sant Pau (ES)
- Hospital Clínico San Carlos (ES)
- Hospital Universitario 12 De Octubre (ES)
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
- Institut Català d'Oncologia (ES)
- Navarre Institute of Health Research (ES)
- Instituto de Investigación Marqués de Valdecilla (ES)
- Hospital Universitario de Burgos (ES)
- Hospital General Universitario de Elche (ES)
- Hospital General Universitario de Ciudad Real (ES)
- Navarrabiomed (ES)
- Policlínica Gipuzkoa (ES)
- Hospital General Universitario De Valencia (ES)
- Instituto de Investigación Biomédica de Salamanca (ES)
- Instituto de Investigación Sanitaria Aragón (ES)
- Santa Lucía University General Hospital (ES)
- Hospital Jerez Puerta del Sur (ES)
- Complejo Hospitalario de Ourense (ES)
Publication Details
- Journal
- Clinical & Translational Oncology
- Published
- 2025-08-09
- DOI
- https://doi.org/10.1007/s12094-025-04010-z
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- Roche
- AstraZeneca España
- Eisai
- Universidad de Cantabria